Great for Niche Indications but Currently Overhyped – A 20:80 DCB to DES Ratio Should Suffice –
Presenter
Manish A. Parikh, M.D., FSCAI, Weill Cornell Medicine, New York, NY
Manish A. Parikh, M.D., FSCAI, Weill Cornell Medicine, New York, NY
Learning Objectives:
- Justify the continued use of DES as the dominant strategy.
- Identify limitations and risks of broad DCB adoption.
- Balance innovation with evidence in procedural decision-making.